Addus HomeCare Co. (NASDAQ:ADUS) Given Consensus Rating of “Buy” by Brokerages

Shares of Addus HomeCare Co. (NASDAQ:ADUS) have been assigned an average rating of “Buy” from the ten research firms that are covering the firm, MarketBeat reports. One investment analyst has rated the stock with a sell rating, seven have assigned a buy rating and two have given a strong buy rating to the company. The average 12-month price target among brokers that have updated their coverage on the stock in the last year is $132.78.

A number of equities analysts recently commented on the company. Oppenheimer lifted their price objective on Addus HomeCare from $145.00 to $150.00 and gave the stock an “outperform” rating in a research note on Friday, January 24th. Citizens Jmp raised Addus HomeCare to a “strong-buy” rating in a research note on Monday, December 16th. StockNews.com lowered Addus HomeCare from a “buy” rating to a “hold” rating in a research note on Wednesday, February 26th. Stephens reaffirmed an “overweight” rating and issued a $142.00 price objective on shares of Addus HomeCare in a research note on Wednesday, March 12th. Finally, JMP Securities initiated coverage on Addus HomeCare in a research note on Monday, December 16th. They issued an “outperform” rating and a $150.00 price objective on the stock.

Insider Buying and Selling at Addus HomeCare

In other news, CEO R Dirk Allison sold 25,000 shares of the business’s stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $124.76, for a total transaction of $3,119,000.00. Following the completion of the sale, the chief executive officer now owns 79,397 shares in the company, valued at $9,905,569.72. The trade was a 23.95 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Insiders own 4.60% of the company’s stock.

Institutional Investors Weigh In On Addus HomeCare

Hedge funds and other institutional investors have recently modified their holdings of the company. Quarry LP bought a new stake in shares of Addus HomeCare during the third quarter valued at approximately $28,000. Natixis increased its holdings in shares of Addus HomeCare by 111.9% during the fourth quarter. Natixis now owns 250 shares of the company’s stock valued at $31,000 after acquiring an additional 132 shares in the last quarter. Smartleaf Asset Management LLC increased its holdings in shares of Addus HomeCare by 324.2% during the fourth quarter. Smartleaf Asset Management LLC now owns 280 shares of the company’s stock valued at $35,000 after acquiring an additional 214 shares in the last quarter. Parkside Financial Bank & Trust grew its holdings in Addus HomeCare by 38.6% during the fourth quarter. Parkside Financial Bank & Trust now owns 531 shares of the company’s stock worth $67,000 after buying an additional 148 shares in the last quarter. Finally, Meeder Asset Management Inc. bought a new stake in Addus HomeCare during the fourth quarter worth $77,000. Institutional investors own 95.35% of the company’s stock.

Addus HomeCare Trading Down 1.2 %

Shares of ADUS stock opened at $89.83 on Monday. The business’s 50-day moving average price is $111.83 and its 200-day moving average price is $121.87. Addus HomeCare has a 12 month low of $87.88 and a 12 month high of $136.72. The firm has a market capitalization of $1.63 billion, a price-to-earnings ratio of 20.56, a PEG ratio of 1.41 and a beta of 0.97.

Addus HomeCare (NASDAQ:ADUS) last announced its quarterly earnings results on Monday, February 24th. The company reported $1.26 EPS for the quarter, missing analysts’ consensus estimates of $1.35 by ($0.09). The firm had revenue of $297.14 million for the quarter, compared to analyst estimates of $291.04 million. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. On average, sell-side analysts predict that Addus HomeCare will post 4.59 earnings per share for the current fiscal year.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.